Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Ann Rheum Dis · 2013 · PMC3595979 · PMID 22532633

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

difference was apparentno p-value reported

No significant difference was apparent when comparing the rates of shingles with etanercept with the monoclonal antibodies combined.

also in 830 other papers

did not reach statistical significanceno p-value reported

The differences did not reach statistical significance when adalimumab was compared with either etanercept or infliximab.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.